Aethlon Stock Pulls Back: What's Going On?
Aethlon Medical Inc. (NASDAQ: AEMD) shares are dropping Friday, pulling back after the stock surged more than 300% the previous day.
Stocks · News reference
Aethlon Medical To Merge With North Immunology; AEMD Holders To Retain ~4.75% Of Combined Company, With North Immunology Stockholders To Own ~95.25%; NewCo Expected To Have Pro Forma Equity Value Of ~$346.5M; Oversubscribed $180M Private Placement Expected To Fund NewCo Operations Into H2 2028
Aethlon Medical, Inc. (NASDAQ:AEMD) ("Aethlon" or the "Company") today announced that it has entered into a definitive merger agreement (the "Agreement") for an all-stock transaction with North
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Aethlon Medical Q1 2027 Earnings Call Transcript
Aethlon Medical (NASDAQ:AEMD) held its first-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For comprehensive financial data and
Aethlon Medical, Oklo, CID HoldCo, Xenon Pharmaceuticals and Moderna: Why These 5 Stocks Are on Investors' Radars Today
Major U.S. indices closed higher on Thursday, with the Dow Jones Industrial Average rising 0.61% to 51,778.04
Crude Oil Down 1%; US Pending Home Sales Rise 0.3% In August
U.S. stocks climbed, led by tech; S&P 500 rose 1.05%. AEMD surged 390%, while RETO plunged 89%. Oil fell, gold and silver gained.